Literature DB >> 16252518

Comparative susceptibility of three species of Anopheles from Belize, Central America, to Plasmodium falciparum (NF-54).

John P Grieco1, Nicole L Achee, Donald R Roberts, Richard G Andre.   

Abstract

In August of 2000, a comparative susceptibility study was conducted using 3 species of Anopheles mosquitoes from Belize, Central America, and a standard species used in laboratory infection studies, Anopheles stephensi. Test populations were fed human blood infected with cultured Plasmodium falciparum (NF-54 strain) parasites via a membrane feeder. The control species, An. stephensi, exhibited the highest infections, with 73.8% of dissected specimens positive for sporozoites in the salivary glands. The control species also showed heavier sporozoite loads; 74.0% of positive glands having greater than 200 sporozoites. Of species from Belize, Anopheles darlingi was the most susceptibile, e.g., 41.0% of salivary glands were positive, with more than 200 sporozoites per gland. Anopheles vestitipennis had a low salivary gland infection rate (9.3%) and a moderate number of sporozoites in glands (i.e., 85.7% containing 50-250 sporozoites). Anopheles albimanus was the least susceptible species to infection. No specimens of An. albimanus from the Golden Stream population developed sporozoites in the salivary glands, yet 20.7% of dissected specimens had positive midgut infections. The An. albimanus Buena Vista population showed similar results with only a 2.2% salivary gland infection rate and a 21.5% midgut infection rate. Oocysts in An. stephensi increased in size by 20% after day 10. Development peaked at day 12, with a mean oocyst diameter of 58 microm at onset of oocyst differentiation. Oocysts developed more slowly in An. vestitipennis until day 10. After day 10, there was a 53% increase in oocyst development over the previous 10 days. Oocyst differentiation was not observed until day 13 postfeed. As with An. vestitipennis, both populations of An. albimanus showed similar slow rates of oocyst development; however, no dramatic growth increase occurred after day 10. The oocysts in the Golden Stream population exhibited a cessation of growth after day 10, peaking at a mean of 30 microm. The Buena Vista population did not exhibit the same level of reduced oocyst development. A gradual increase in growth continued until days 13 and 14 (36.7 and 35.7 microm, respectively).

Entities:  

Mesh:

Year:  2005        PMID: 16252518     DOI: 10.2987/8756-971X(2005)21[279:CSOTSO]2.0.CO;2

Source DB:  PubMed          Journal:  J Am Mosq Control Assoc        ISSN: 8756-971X            Impact factor:   0.917


  19 in total

1.  Malaria in selected non-Amazonian countries of Latin America.

Authors:  Myriam Arevalo-Herrera; Martha Lucia Quiñones; Carlos Guerra; Nora Céspedes; Sandra Giron; Martha Ahumada; Juan Gabriel Piñeros; Norma Padilla; Zilka Terrientes; Angel Rosas; Julio Cesar Padilla; Ananias A Escalante; John C Beier; Socrates Herrera
Journal:  Acta Trop       Date:  2011-07-01       Impact factor: 3.112

2.  Plasmodium vivax sporozoite production in Anopheles albimanus mosquitoes for vaccine clinical trials.

Authors:  Yezid Solarte; María R Manzano; Leonardo Rocha; Hugo Hurtado; Mark A James; Myriam Arévalo-Herrera; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

3.  The dominant Anopheles vectors of human malaria in the Americas: occurrence data, distribution maps and bionomic précis.

Authors:  Marianne E Sinka; Yasmin Rubio-Palis; Sylvie Manguin; Anand P Patil; Will H Temperley; Peter W Gething; Thomas Van Boeckel; Caroline W Kabaria; Ralph E Harbach; Simon I Hay
Journal:  Parasit Vectors       Date:  2010-08-16       Impact factor: 3.876

4.  Plasmodium evasion of mosquito immunity and global malaria transmission: The lock-and-key theory.

Authors:  Alvaro Molina-Cruz; Gaspar E Canepa; Nitin Kamath; Noelle V Pavlovic; Jianbing Mu; Urvashi N Ramphul; Jose Luis Ramirez; Carolina Barillas-Mury
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

5.  Evidence for pleistocene population divergence and expansion of Anopheles albimanus in Southern Central America.

Authors:  Jose R Loaiza; Marilyn E Scott; Eldredge Bermingham; Jose Rovira; Jan E Conn
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

6.  Geometric morphometric analysis of Colombian Anopheles albimanus (Diptera: Culicidae) reveals significant effect of environmental factors on wing traits and presence of a metapopulation.

Authors:  Giovan F Gómez; Edna J Márquez; Lina A Gutiérrez; Jan E Conn; Margarita M Correa
Journal:  Acta Trop       Date:  2014-04-02       Impact factor: 3.112

7.  Ookinete destruction within the mosquito midgut lumen explains Anopheles albimanus refractoriness to Plasmodium falciparum (3D7A) oocyst infection.

Authors:  Luke A Baton; Lisa C Ranford-Cartwright
Journal:  Int J Parasitol       Date:  2012-02-18       Impact factor: 3.981

8.  Microsatellite data suggest significant population structure and differentiation within the malaria vector Anopheles darlingi in Central and South America.

Authors:  Lisa Mirabello; Joseph H Vineis; Stephen P Yanoviak; Vera M Scarpassa; Marinete M Póvoa; Norma Padilla; Nicole L Achee; Jan E Conn
Journal:  BMC Ecol       Date:  2008-03-26       Impact factor: 2.964

9.  Hyperendemic malaria transmission in areas of occupation-related travel in the Peruvian Amazon.

Authors:  Benjamin S Parker; Maribel Paredes Olortegui; Pablo Peñataro Yori; Karin Escobedo; David Florin; Silvia Rengifo Pinedo; Roldan Cardenas Greffa; Luis Capcha Vega; Hugo Rodriguez Ferrucci; William K Pan; Cesar Banda Chavez; Joseph M Vinetz; Margaret Kosek
Journal:  Malar J       Date:  2013-05-31       Impact factor: 2.979

10.  Phenotypic dissection of a Plasmodium-refractory strain of malaria vector Anopheles stephensi: the reduced susceptibility to P. berghei and P. yoelii.

Authors:  Naoaki Shinzawa; Tomoko Ishino; Mayumi Tachibana; Takafumi Tsuboi; Motomi Torii
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.